Shenzhen New Industries Biomedical Engineering Co. Ltd. Class ASZSE: 300832

2025 revenue rose 0.91% to ¥4.58B, with net profit down 11.39% amid strong overseas growth

· Issued by Shenzhen New Industries Biomedical Engineering Co. Ltd. Class A

Revenue grew 0.91% to ¥4.58 billion in 2025, with net profit down 11.39% to ¥1.62 billion. Overseas business surged 19.16%, offsetting domestic declines from regulatory pressures, while high-end instrument launches and strong R&D investment supported future growth.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

Company analysis

Earlier from Shenzhen New Industries Biomedical Engineering Co. Ltd. Class A

All Shenzhen New Industries Biomedical Engineering Co. Ltd. Class A news releases